The results of the trial align with earlier studies conducted in Europe, where UroShield improved patient outcomes.
The "United States Syringes, Needles and Urinary Catheters Market Outlook to 2033 - Needles, Syringes and Urinary Catheters" report has been added to ResearchAndMarkets.com's offering.The ...
NanoVibronix (Nasdaq:NAOV) announced today that it completed the first phase of a randomized controlled trial for its ...
However, a commercial replacement gastrostomy tube is many times more expensive than a Foley catheter, and the two have never been compared. We compared the efficacy and safety of an all-silicone ...
BuzzFeed on MSN6d
This Woman Shocked The Internet By Revealing "Postpartum Stink" Is A Thing, So Experts Are Explaining Why This Happens To New Moms"The reason [for postpartum smell] is the drastic change in hormones occurring as the body no longer supports pregnancy and ...
UroShield was developed by NanoVibronix to prevent bacterial colonisation and biofilm formation on indwelling urinary ...
You had obstruction of the urinary tract. In adult men, the most common cause by far is prostate enlargement. The entire ...
Verywell Health on MSN6d
Can Kidney Stones Cause a UTI, or Vice Versa?Yes, kidney stones can cause urinary tract infections (UTIs) and vice versa. But it's a chicken-and-egg dilemma. Here’s why, ...
I am a 63-year-old male in good health. A few weeks back, I could not urinate while standing. The only way I could was by ...
Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms through innovations in urodynamics, today announced a Translational Research Award of $1.75 ...
Benign prostate enlargement is not cancerous and is very common—particularly in men after they reach the age of 50.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback